Is SOPHiA GENETICS SA halal to invest in?

According to Musaffa's Shariah screening methodology, SOPHiA GENETICS SA (SOPH) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is SOPHiA GENETICS SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SOPHiA GENETICS SA using these criteria to determine its compliance status.

Can Muslims buy shares of SOPHiA GENETICS SA?

Muslim investors may consider investing in SOPHiA GENETICS SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is SOPHiA GENETICS SA classified as HALAL?

Musaffa determines the Shariah status of SOPHiA GENETICS SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for SOPHiA GENETICS SA updated?

The Shariah compliance status of SOPHiA GENETICS SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like SOPHiA GENETICS SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of SOPHiA GENETICS SA?

You can check the latest Shariah compliance status of SOPHiA GENETICS SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SOPH Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 27, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for SOPHiA GENETICS SA (SOPH)

Based on 10 analysts giving stock ratings to SOPHiA GENETICS SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

SOPHiA GENETICS SA. Stock Analysis SOPH

United States Health Care Small Cap Report: 2025 Annual

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 415 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.

Key Statistics of SOPHiA GENETICS SA (SOPH)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.55$4.76

Today's Open

$4.64

Volume

46.18K

P/E Ratio (TTM)

52 Week Range

$2.59$5.70

Market Cap

363.36M

Avg. Volume

113.29K

Dividend Yield

Financial Metrics & Statements of SOPHiA GENETICS SA (SOPH)

FAQ's for SOPHiA GENETICS SA (SOPH)

According to Musaffa’s Shariah screening methodology, SOPHiA GENETICS SA (SOPH) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.